Amicus Therapeutics, Inc (FOLD)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 511
- Market Cap
- $4.5B
About Amicus Therapeutics, Inc
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
SentiSense also tracks daily options readings for Amicus Therapeutics, Inc: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Amicus Therapeutics, Inc stock analysis, sentiment tracking, and market intelligence on SentiSense.